|
1
|
Coupland VH, Lagergren J, Lüchtenborg M,
Jack RH, Allum W, Holmberg L, Hanna GB, Pearce N and Møller H:
Hospital volume, proportion resected and mortality from oesophageal
and gastric cancer: A population-based study in England, 2004–2008.
Gut. 62:961–966. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Camargo MC, Kim WH, Chiaravalli AM, Kim
KM, Corvalan AH, Matsuo K, Yu J, Sung JJ, Herrera-Goepfert R,
Meneses-Gonzalez F, et al: Improved survival of gastric cancer with
tumour Epstein-Barr virus positivity: An international pooled
analysis. Gut. 63:236–243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shibata W, Ariyama H, Westphalen CB,
Worthley DL, Muthupalani S, Asfaha S, Dubeykovskaya Z, Quante M,
Fox JG and Wang TC: Stromal cell-derived factor-1 overexpression
induces gastric dysplasia through expansion of stromal
myofibroblasts and epithelial progenitors. Gut. 62:192–200. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang S, Wu X, Zhang J, Chen Y, Xu J, Xia
X, He S, Qiang F, Li A, Shu Y, et al: CHIP functions as a novel
suppressor of tumour angiogenesis with prognostic significance in
human gastric cancer. Gut. 62:496–508. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paterson AL, Shannon NB, Lao-Sirieix P,
Ong CA, Peters CJ, O'Donovan M and Fitzgerald RC: A systematic
approach to therapeutic target selection in oesophago-gastric
cancer. Gut. 62:1415–1424. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang M, Qiu Z, Zhang S, Fan X, Cai X, Xu
B, Li X, Zhou J, Zhang X, Chu Y, et al: Elevated O-GlcNAcylation
promotes gastric cancer cells proliferation by modulating cell
cycle related proteins and ERK 1/2 signaling. Oncotarget.
7:61390–61402. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou Q, Wang X, Yu Z, Wu X, Chen X, Li J,
Zhu Z, Liu B and Su L: Transducin (β)-like 1 X-linked receptor 1
promotes gastric cancer progression via the ERK1/2 pathway.
Oncogene. 36:1873–1886. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang X, Hua R, Wang X, Huang M, Gan L, Wu
Z, Zhang J, Wang H, Cheng Y, Li J and Guo W: Identification of
stem-like cells and clinical significance of candidate stem cell
markers in gastric cancer. Oncotarget. 7:9815–9831. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kholodenko BN, Hancock JF and Kolch W:
Signalling ballet in space and time. Nat Rev Mol Cell Biol.
11:414–426. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kong X, Qian J, Chen LS, Wang YC, Wang JL,
Chen H, Weng YR, Zhao SL, Hong J, Chen YX, et al: Synbindin in
extracellular signal-regulated protein kinase spatial regulation
and gastric cancer aggressiveness. J Natl Cancer Inst.
105:1738–1749. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong L, Qi N, Ge RM, Cao CL, Lan F and
Shen L: Overexpression of CD133 promotes the phosphorylation of Erk
in U87MG human glioblastoma cells. Neurosci Lett. 484:210–214.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
15
|
Hermann PC, Huber SL, Herrler T, Aicher A,
Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations
of cancer stem cells determine tumor growth and metastatic activity
in human pancreatic cancer. Cell Stem Cell. 1:313–323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aomatsu N, Yashiro M, Kashiwagi S,
Takashima T, Ishikawa T, Ohsawa M, Wakasa K and Hirakawa K: CD133
is a useful surrogate marker for predicting chemosensitivity to
neoadjuvant chemotherapy in breast cancer. PLoS One. 7:e458652012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu Y, Yu J, Wang S, Lu R, Wu J and Jiang
B: Overexpression of CD133 enhances chemoresistance to
5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric
cancer cells. Oncol Rep. 32:2437–2444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ding W, Mouzaki M, You H, Laird JC, Mato
J, Lu SC and Rountree CB: CD133+ liver cancer stem cells
from methionine adenosyl transferase1 A-deficient mice demonstrate
resistance to transforming growth factor (TGF)-beta-induced
apoptosis. Hepatology. 49:1277–1286. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang YK, Zhu YL, Qiu FM, Zhang T, Chen ZG,
Zheng S and Huang J: Activation of Akt and MAPK pathways enhances
the tumorigenicity of CD133+ primary colon cancer cells.
Carcinogenesis. 31:1376–1380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
El-Khattouti A, Selimovic D, Haïkel Y,
Megahed M, Gomez CR and Hassan M: Identification and analysis of
CD133(+) melanoma stem-like cells conferring resistance to taxol:
An insight into the mechanisms of their resistance and response.
Cancer Lett. 343:123–133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Borrego-Diaz E, Terai K, Lialyte K, Wise
AL, Esfandyari T, Behbod F, Mautner VF, Spyra M, Taylor S, Parada
LF, et al: Overactivation of Ras signaling pathway in
CD133+ MPNST cells. J Neurooncol. 108:423–434. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vangipuram SD, Wang ZJ and Lyman WD:
Resistance of stem-like cells from neuroblastoma cell lines to
commonly used chemotherapeutic agents. Pediatr Blood Cancer.
54:361–368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mucsi I, Skorecki KL and Goldberg HJ:
Extracellular signal-regulated kinase and the small GTP-binding
protein, Rac, contribute to the effects of transforming growth
factor-beta1 on gene expression. J Biol Chem. 271:16567–16572.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Atfi A, Djelloul S, Chastre E, Davis R and
Gespach C: Evidence for a role of Rho-like GTPases and
stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK)
in transforming growth factor beta-mediated signaling. J Biol Chem.
272:1429–1432. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bakin AV, Tomlinson AK, Bhowmick NA, Moses
HL and Arteaga CL: Phosphatidylinositol 3-kinase function is
required for transforming growth factor beta-mediated epithelial to
mesenchymal transition and cell migration. J Biol Chem.
275:36803–36810. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bhowmick NA, Ghiassi M, Bakin A, Aakre M,
Lundquist CA, Engel ME, Arteaga CL and Moses HL: Transforming
growth factor-beta1 mediates epithelial to mesenchymal
transdifferentiation through a RhoA-dependent mechanism. Mol Biol
Cell. 12:27–36. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
You H, Ding W and Rountree CB: Epigenetic
regulation of cancer stem cell marker CD133 by transforming growth
factor-beta. Hepatology. 51:1635–1644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu RQ, Wu JG, Zhou GC, Jiang HG, Yu JW and
Jiang BJ: Sorting of CD133(+) subset cells in human gastric cancer
and the identification of their tumor initiating cell-like
properties. Zhonghua Wei Chang Wai Ke Za Zhi. 15:174–179. 2012.(In
Chinese). PubMed/NCBI
|
|
30
|
Takaishi S, Okumura T, Tu S, Wang SS,
Shibata W, Vigneshwaran R, Gordon SA, Shimada Y and Wang TC:
Identification of gastric cancer stem cells using the cell surface
marker CD44. Stem Cells. 27:1006–1020. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Platet N, Liu SY, Atifi ME, Oliver L,
Vallette FM, Berger F and Wion D: Influence of oxygen tension on
CD133 phenotype in human glioma cell cultures. Cancer Lett.
258:286–290. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
McCord AM, Jamal M, Shankavarum UT, Lang
FF, Camphausen K and Tofilon PJ: Physiologic oxygen concentration
enhances the stem-like properties of CD133+ human
glioblastoma cells in vitro. Mol Cancer Res. 7:489–497. 2009.
View Article : Google Scholar : PubMed/NCBI
|
